The prebiotic and probiotic market experiences significant growth during the pandemic. Digestive issues remain one of the top problems plaguing U.S. consumers. Digestive diseases affect 60 to 70 million people each year, according to the National Ambulatory Medical Care Survey. Another survey found heartburn/reflux, abdominal pain, bloating, diarrhea and constipation to be the top issues consumers suffer with. As a result, digestive health remains top of mind and consumers often turn to prebiotics and probiotics as a solution. Once the world was hit by the COVID-19 pandemic and left to grapple with its impacts, consumer demand for prebiotics and probiotics grew even stronger. In 2020, probiotics remained one of the top selling supplements in the U.S. and the market was valued at $2,971.87 million last year, according to a 2020 report. Additionally, according to data by Meticulous Market Research, the probiotics market is expected to grow at a compound annual growth rate (CAGR) of 5.6 percent from 2020 to 2027 and reach $75.9 billion by the end of that timeline. What’s driving the continued growth? “This growth is driven by the expanding consumer inclination toward preventive health care in conjunction with the development of efficient probiotic strains and effective prebiotic [...]
The post Prebiotics, Probiotics and COVID-19 appeared first on Vitamin Retailer Magazine.